corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 7652

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Journal Article

Vivian JC.
Federal limits on gifts from pharmaceutical companies
US Pharmacist 2002; 27:(11):96-98,101


Abstract:

An overview of a new compliance guideline issued 30 September 2002 by the Office of the Inspector General (OIG) of the Department of Health and Human Services entitled OIG Compliance Program Guidance for Pharmaceutical Manufacturers, which targets marketing activities routinely employed by pharmaceutical companies to influence physicians’ prescribing habits, is presented, and maintenance of the integrity of data used to establish government reimbursement, enforcement of the Prescription Drug Marketing Act of 1987, which governs the distribution of drug samples and forbids their sale, and various aspects of relationships between the pharmaceutical industry and health care professionals are considered.

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








...to influence multinational corporations effectively, the efforts of governments will have to be complemented by others, notably the many voluntary organisations that have shown they can effectively represent society’s public-health interests…
A small group known as Healthy Skepticism; formerly the Medical Lobby for Appropriate Marketing) has consistently and insistently drawn the attention of producers to promotional malpractice, calling for (and often securing) correction. These organisations [Healthy Skepticism, Médecins Sans Frontières and Health Action International] are small, but they are capable; they bear malice towards no one, and they are inscrutably honest. If industry is indeed persuaded to face up to its social responsibilities in the coming years it may well be because of these associations and others like them.
- Dukes MN. Accountability of the pharmaceutical industry. Lancet. 2002 Nov 23; 360(9346)1682-4.